FI82379C - Radioaktivt maerkta monoklonala antikroppar samt en komposition innehaollande dessa och anvaendbar som diagnostiskt radiofarmaseutiskt medel. - Google Patents

Radioaktivt maerkta monoklonala antikroppar samt en komposition innehaollande dessa och anvaendbar som diagnostiskt radiofarmaseutiskt medel. Download PDF

Info

Publication number
FI82379C
FI82379C FI823633A FI823633A FI82379C FI 82379 C FI82379 C FI 82379C FI 823633 A FI823633 A FI 823633A FI 823633 A FI823633 A FI 823633A FI 82379 C FI82379 C FI 82379C
Authority
FI
Finland
Prior art keywords
tumor
antibody
cea
labeled
chelating agent
Prior art date
Application number
FI823633A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI823633A0 (fi
FI82379B (fi
FI823633L (fi
Inventor
Thomas Henry Adams
Gary Samuel David
Samuel Elliot Halpern
Original Assignee
Univ California
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Hybritech Inc filed Critical Univ California
Publication of FI823633A0 publication Critical patent/FI823633A0/fi
Publication of FI823633L publication Critical patent/FI823633L/fi
Application granted granted Critical
Publication of FI82379B publication Critical patent/FI82379B/fi
Publication of FI82379C publication Critical patent/FI82379C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1066—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI823633A 1981-10-27 1982-10-25 Radioaktivt maerkta monoklonala antikroppar samt en komposition innehaollande dessa och anvaendbar som diagnostiskt radiofarmaseutiskt medel. FI82379C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31528681A 1981-10-27 1981-10-27
US31528681 1981-10-27

Publications (4)

Publication Number Publication Date
FI823633A0 FI823633A0 (fi) 1982-10-25
FI823633L FI823633L (fi) 1983-04-28
FI82379B FI82379B (fi) 1990-11-30
FI82379C true FI82379C (fi) 1991-03-11

Family

ID=23223718

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823633A FI82379C (fi) 1981-10-27 1982-10-25 Radioaktivt maerkta monoklonala antikroppar samt en komposition innehaollande dessa och anvaendbar som diagnostiskt radiofarmaseutiskt medel.

Country Status (18)

Country Link
JP (1) JPS58135820A (fr)
AT (1) AT392004B (fr)
BE (1) BE894829A (fr)
CA (1) CA1202892A (fr)
CH (1) CH653040A5 (fr)
DE (1) DE3239410A1 (fr)
DK (1) DK164682C (fr)
ES (2) ES516797A0 (fr)
FI (1) FI82379C (fr)
FR (1) FR2515046B1 (fr)
GB (1) GB2109407B (fr)
IL (1) IL67068A0 (fr)
IT (1) IT1153857B (fr)
LU (1) LU84441A1 (fr)
NL (1) NL8204108A (fr)
NO (1) NO169947C (fr)
SE (1) SE8206073L (fr)
ZA (1) ZA827806B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
CA1225930A (fr) * 1982-06-07 1987-08-25 Otto A. Gansow Anticorps monoclonaux conjugues avec des chelates metalliques
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB2140030A (en) * 1983-04-08 1984-11-21 Kureha Chemical Ind Co Ltd Monoclonal antibody to human urinary bladder cancer
GB2139645A (en) * 1983-04-08 1984-11-14 Kureha Chemical Ind Co Ltd Antibody to human prostrate cancer
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
CA1260827A (fr) * 1984-08-31 1989-09-26 Richard C. Siegel Complexes anticorps - ions metalliques
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US5082930A (en) * 1986-05-29 1992-01-21 Mallinckrodt Medical, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4925804A (en) * 1986-06-17 1990-05-15 Baxter International Inc. Interligand metal transfer assay
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
CA1340014C (fr) * 1986-10-27 1998-08-25 Bryan Michael Longenecker Anticorps monoclonaux marqueurs de carcinomes; leur elicitation avec l'antigene asialo-gmi
US5227474A (en) * 1987-02-13 1993-07-13 Abbott Laboratories Bifunctional chelating agents
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US4838274A (en) * 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5217704A (en) * 1987-11-06 1993-06-08 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5688488A (en) * 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5550160A (en) * 1992-07-31 1996-08-27 Australian Nuclear Science & Technology Organization Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US6558669B1 (en) 1996-08-28 2003-05-06 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis
US7521531B2 (en) 1996-08-28 2009-04-21 Immunomedics, Inc. Methods for the purification of stable radioiodine conjugates
US6663866B1 (en) 1996-08-28 2003-12-16 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
JPH036125B2 (fr) * 1980-03-03 1991-01-29 Miruton Deebitsudo Goorudenbaagu

Also Published As

Publication number Publication date
FR2515046B1 (fr) 1985-11-29
AT392004B (de) 1991-01-10
DK164682B (da) 1992-08-03
IT1153857B (it) 1987-01-21
NL8204108A (nl) 1983-05-16
CH653040A5 (de) 1985-12-13
NO169947C (no) 1992-08-26
ATA391682A (de) 1990-07-15
NO823530L (no) 1983-04-28
JPH0564130B2 (fr) 1993-09-14
FI823633A0 (fi) 1982-10-25
ES8505482A1 (es) 1985-05-16
DK164682C (da) 1992-12-21
GB2109407B (en) 1985-12-18
IT8223932A0 (it) 1982-10-26
ES8404857A1 (es) 1984-05-16
FR2515046A1 (fr) 1983-04-29
CA1202892A (fr) 1986-04-08
FI82379B (fi) 1990-11-30
GB2109407A (en) 1983-06-02
BE894829A (fr) 1983-02-14
IL67068A0 (en) 1983-02-23
DE3239410C2 (fr) 1991-12-19
NO169947B (no) 1992-05-18
DE3239410A1 (de) 1983-05-19
ES516797A0 (es) 1984-05-16
DK474182A (da) 1983-04-28
SE8206073L (sv) 1983-04-28
ES529310A0 (es) 1985-05-16
JPS58135820A (ja) 1983-08-12
SE8206073D0 (sv) 1982-10-26
FI823633L (fi) 1983-04-28
ZA827806B (en) 1983-08-31
LU84441A1 (fr) 1983-06-13

Similar Documents

Publication Publication Date Title
FI82379C (fi) Radioaktivt maerkta monoklonala antikroppar samt en komposition innehaollande dessa och anvaendbar som diagnostiskt radiofarmaseutiskt medel.
Halpern et al. Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models
Anderson et al. Copper-64-labeled antibodies for PET imaging
Scheinberg et al. Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice
Chinn et al. Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma.
US4634586A (en) Reagent and method for radioimaging leukocytes
Garg et al. Comparative tissue distribution in mice of the α-emitter 211At and 131I as labels of a monoclonal antibody and F (ab′) 2 fragment
Bernhard et al. Localization of 111In-and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors
Goodwin et al. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system
Anderson et al. Stability, targeting, and biodistribution of scandium-46-and gallium-67-labeled monocolonal antibody in erythroleukemic mice
DeNardo et al. Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma
Andrew et al. A comparison of iodine and indium labelled anti CEA intact antibody, F (ab) 2 and Fab fragments by imaging tumour xenografts
Sakahara et al. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111
Stein et al. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small-cell carcinoma of the lung
Buchsbaum et al. Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indium
Thakur et al. Technetium-99m-labeled proteins for imaging inflammatory foci
Alauddin et al. An improved method of direct labeling monoclonal antibodies with 99mTc
Epstein et al. Radioimmunodetection of human B-cell lymphomas with a radiolabeled tumor-specific monoclonal antibody (Lym-1)
Kobayashi et al. Repeating the avidin “chase” markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity
Page et al. Preclinical evaluation and PET imaging of 18F-labeled Mel-14 F (ab′) 2 fragment in normal dogs
Hansen et al. Labeling of anti-tumor antibodies and antibody fragments with Tc-99m
Gadina et al. Preclinical pharmacokinetics and localization studies of the radioiodinated anti-ovarian carcinoma MAb MOv18
Singh et al. A simplified kit for instant preparation of technerium-99m human immunoglobulin-G for imaging inflammatory foci
Zalutsky Radiohalogens for radioimmunotherapy
Lavie et al. Evaluation of L6, an anti-carcinoma murine monoclonal antibody, in tumor-bearing nude mice

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: HYBRITECH INCORPORATED

Owner name: THE REGENTS OF THE UNIVERSITY OF